Cisplatin and Platinum Pharmacokinetics in Hyperthermic Isolated Limb Perfusion
Author Information
Author(s): H.-J. Guchelaarl, H.J. Hoekstra, E.G.E. de Vries, D.R.A. Uges, J.W. Oosterhuis, H. Schraffordt Koops
Primary Institution: University Hospital Groningen
Hypothesis
What are the pharmacokinetics of cisplatin during hyperthermic isolated limb perfusion for human tumors?
Conclusion
The study found that hyperthermic isolated limb perfusion allows for higher concentrations of cisplatin with relatively low systemic leakage.
Supporting Evidence
- High concentrations of cisplatin can be achieved in the limb with minimal systemic exposure.
- Patients experienced moderate to severe local toxicity but no systemic side effects.
- Pharmacokinetic parameters indicated significant drug extraction during the procedure.
Takeaway
Doctors can use a special method to treat tumors in arms and legs with a strong medicine called cisplatin, and it works better without making the whole body sick.
Methodology
The study involved nine patients receiving hyperthermic isolated limb perfusion with cisplatin, measuring drug concentrations in the perfusate and tissue samples.
Limitations
The study had a small sample size and variability in patient limb volumes.
Participant Demographics
Patients included six with melanoma, one with osteosarcoma, and two with malignant fibrous histiocytoma, aged 21 to 72 years.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website